U.S. markets open in 2 hours 1 minute

Alcon Inc. (ALC)

NYSE - NYSE Delayed Price. Currency in USD
Add to watchlist
68.26-2.17 (-3.08%)
At close: 4:00PM EST

68.04 -0.22 (-0.32%)
Pre-Market: 6:46AM EST

Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Bullishpattern detected
Fast Stochastic

Fast Stochastic

Previous Close70.43
Bid68.35 x 800
Ask68.15 x 800
Day's Range68.09 - 69.28
52 Week Range39.37 - 76.26
Avg. Volume919,464
Market Cap33.744B
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-1.09
Earnings DateN/A
Forward Dividend & Yield0.11 (0.16%)
Ex-Dividend DateApr 30, 2021
1y Target Est75.82
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
View more
  • Alcon’s Sue-Jean Lin Wins 2021 Dallas CIO of the Year
    Business Wire

    Alcon’s Sue-Jean Lin Wins 2021 Dallas CIO of the Year

    Alcon’s Sue-Jean Lin Wins 2021 Dallas CIO of the Year

  • Alcon Inc (ALC) Q4 2020 Earnings Call Transcript
    Motley Fool

    Alcon Inc (ALC) Q4 2020 Earnings Call Transcript

    ALC earnings call for the period ending December 31, 2020.

  • Benzinga

    Recap: Alcon Q4 Earnings

    Shares of Alcon (NYSE:ALC) were flat in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share decreased 8.89% over the past year to $0.41, which were in line with the estimate of $0.41. Revenue of $1,925,000,000 higher by 2.34% year over year, which beat the estimate of $1,890,000,000. Guidance Earnings guidance hasn't been issued by the company for now. View more earnings on ALC Revenue guidance hasn't been issued by the company for now. Technicals 52-week high: $76.26 Company's 52-week low was at $39.37 Price action over last quarter: Up 10.91% Company Profile Alcon, headquartered in Fort Worth, Texas, is the global eyecare leader with a diverse portfolio in ophthalmology including contact lenses, eye drops, surgical equipment, and related surgical products. Novartis purchased Alcon from Nestle in 2010 and, following nine years as a Novartis subsidiary, the company was spun-off as a public company in April 2019. The company reports five distinct segments: implantables (16% of revenue), consumables (31%), equipment (9%), contact lenses (27%), and ocular health (17%). The company is geographically diversified, with 41% of revenue in the U.S. market, and the firm has a strong presence in the European Union and Japan. See more from BenzingaClick here for options trades from BenzingaEarnings Scheduled For February 23, 2021© 2021 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.